No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
REGMF REMEGEN CO LTD
- 1.500
- 0.0000.00%
15min DelayClose Sep 16 16:00 ET
816.39MMarket Cap-3.71P/E (TTM)
0.000High0.000Low0Volume0.000Open1.500Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)544.26MShares4.00052wk High2.23P/B816.39MFloat Cap1.50052wk Low--Dividend TTM544.26MShs Float4.000Historical High--Div YieldTTM0.00%Amplitude1.500Historical Low--Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
RemeGen Completes Patient Enrollment in Two Phase III Clinical Trials Using Telitacicept for Treatment of IgA Nephropathy and Primary Sjögren's Syndrome
RemeGen Celebrates World Lupus Day 2024 With Increased Lupus Visibility Through Vital Knowledge Sharing
RemeGen's Telitacicept (RC18) Granted Fast Track Designation by United States FDA for Treatment of Primary Sjögren's Syndrome
Heat List
US
Overall
Symbol
Price
% Chg
No Data